Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MDM2 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

MDM2 mutation	Breast Cancer	MDM2 mutation	Breast Cancer	ribociclib Sensitive: B - Late Trials ribociclib Sensitive : B	ribociclib Sensitive: B - Late Trials ribociclib Sensitive : B
MDM2 mutation	Non Small Cell Lung Cancer	MDM2 mutation	Non Small Cell Lung Cancer	cetuximab + avelumab Sensitive: C3 – Early Trials cetuximab + avelumab Sensitive : C3	cetuximab + avelumab Sensitive: C3 – Early Trials cetuximab + avelumab Sensitive : C3
MDM2 mutation	Non Small Cell Lung Cancer	MDM2 mutation	Non Small Cell Lung Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3